Univercells, a Belgian technology company that strives to bring a fundamental change to the biomanufacturing industry with the ambition to make biologics (e.g. viral vaccines, monoclonal antibodies, enzyme replacement therapies) available and affordable to all by reinventing bioprocess architecture (technology driven affordability).

  • Facebook - Gris Cercle
  • Twitter - Gris Cercle
  • LinkedIn - Gris Cercle

Inventures Investment Partners S.A. — Place Sainte-Gudule 5, 1000 Brussels, Belgium — +32 472 34 14 32 — info@inventures.fund — BE 0693.960.071

Legal Disclaimer